Abstract
Researchers have long investigated a hypothesized interaction between genetic risk and stressful life events in the etiology of depression, but studies on the topic have yielded inconsistent results. We conducted a genome-wide environment interaction study in 18,532 depression cases from hospital-based settings and 20,184 population-representative non-cases from the iPSYCH2012 case-cohort study, a nationally representative sample identified from Danish national registers. Stressful life events including family disruption, serious medical illness, death of a first-degree relative, parental disability and child maltreatment were identified from population-based registers and operationalized as a time-varying count variable (0-4+). Hazard ratios for main and interaction effects were estimated using Cox regressions weighted to accommodate the case-cohort design. The analyses yielded three novel, genome-wide significant (P < 5 × 10-8) loci located in the ATP-binding cassette transporter C 1 (ABCC1) gene, in the A-kinase anchor protein 6 (AKAP6) gene, and near the Major facilitator superfamily domain 1 (MFSD1) gene, as well as 50 loci of suggestive significance. These top 3 hits did not replicate in a case-control sample of depression drawn from the UK Biobank. These results suggest that there may be individual genetic variants that confer risk for or protection against clinical depression only in the presence of stressful life events; however, replication in a sample with similar design and ascertainment methods is needed before any firm conclusions can be drawn. Future gene-by-stress research in depression should focus on establishing even larger collaborative genome-wide environment interaction studies to attain sufficient power.
Competing Interest Statement
Thomas Werge has served as scientific advisor to H. Lundbeck A/S. Gerome Breen has received consultancy and speaker fees from Eli Lilly, Otsuka, and Illumina. The rest of the authors have no conflicts of interest to report.
Funding Statement
This study was funded by a grant from the Lundbeck Foundation (grant numbers R102-A9118, R155-2014-1724 and R248-2017-2003) and the universities and university hospitals of Aarhus and Copenhagen. Katherine Musliner is funded by a postdoctoral fellowship from the Lundbeck Foundation (R303-2018-3551). Genotyping of the iPSYCH2012 samples was supported by grants from the Lundbeck Foundation, the Stanley Foundation, the Simons Foundation (SFARI311789) and the National Institutes of Mental Health (NIMH 5U01MH094432-02). The Danish National Biobank resource is supported by the Novo Nordisk Foundation. The UK Biobank (Project ID 16577) represents independent research supported by the National Institute for Health Research (NIHR) Biomedical Research Center at South London and Maudsley NHS Foundation Trust and King's College London. High performance computing facilities at the NIHR BRC were funded with capital equipment grants from the GSTT Charity (TR130505) and Maudsley Charity (908).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The iPSYCH2012 study was approved by the Danish Scientific Ethics Committee, the Danish Health Data Authority, the Danish Data Protection Agency, and Danish Newborn Screening Biobank Steering Committee. In accordance with Danish law, The Danish Scientific Ethics Committee has for this study waived the need for informed consent in biomedical research based on existing biobanks.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Data referred to in the manuscript are available from Statistics Denmark. Restrictions apply to the availability of these data, which were used under license for this study. For more information on accessing the data see www.dst.dk.
